A Phase I Study of BMS-906024 in Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma
[Protocol 11-181] |
Douer, Dan |
- Leukemia
- Acute Lymphoblastic Leukemia
- Lymphoma
|
The Sexual Health of Rectal Cancer Patients: A Pilot Study
[Protocol 08-073] |
DuHamel, Katherine |
- Colorectal Cancer
- Survivorship
|
A Phase I Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
[Protocol 08-091] |
Dunkel, Ira |
|
A Phase II Study of Response-Based Radiation Therapy for Patients with Localized Germ Cell Tumors of the Central Nervous System
[Protocol 12-243] |
Dunkel, Ira |
- Germ Cell Tumors
- Pediatric Brain Tumors
|
A Phase I Study of AZD6244 in Pediatric Patients with Recurrent or Refractory Low-Grade Glioma (PBTC-029)
[Protocol 12-151] |
Dunkel, Ira |
|
A Phase II Study of Ipilimumab in Children and Adolescents with Stage III/IV Inoperable Melanoma
[Protocol 13-043] |
Dunkel, Ira |
|
Treatment of Atypical Teratoid/Rhabdoid Tumors of the Central Nervous System with Surgery, Intensive Chemotherapy, and 3-D Conformal Radiation
[Protocol 09-070] |
Dunkel, Ira |
|
A Phase III Study of Multimodality Therapy for Extra-ocular Retinoblastoma
[Protocol 08-072] |
Dunkel, Ira |
|
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer (ALTE07C1)
[Protocol 12-241] |
Dunkel, Ira |
|
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
[Protocol 07-041] |
Eastham, James |
|
A Multicenter Study of Sonablate 500 HIFU Treatment for Locally Recurrent Prostate Cancer: the STAR Trial
[Protocol 09-164] |
Eastham, James |
- Prostate Cancer
- Localized Disease
- Rising PSA After Primary Therapy
|
A Phase II Trial of Paclitaxel, Ifosfamide, and Cisplatin in Patients with Previously Untreated Advanced Germ Cell Tumors
[Protocol 07-044] |
Feldman, Darren |
|
Adolescent and Young Adult Cancer Survivors: Identity Development
[Protocol 09-001] |
Ford, Jennifer |
|
A Phase I-II Study of Dasatinib plus Paclitaxel in Patients with Metastatic Breast Cancer
[Protocol 08-122] |
Fornier, Monica |
|
A Phase II Study of Cabozantinib in Women with Hormone Receptor-Positive Breast Cancer that Spread to the Bone
[Protocol 12-091] |
Fornier, Monica |
|
A Phase II Trial of Bevacizumab, Cetuximab, Cisplatin, and Intensity-Modulated Radiation Therapy for Patients with Stage III/IV Head and Neck Squamous Cell Carcinoma
[Protocol 09-083] |
Fury, Matthew |
|
A Phase I/II Study of Temsirolimus, Paclitaxel, and Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer
[Protocol 09-131] |
Fury, Matthew |
|
A Pilot Study to Assess the Pharmacodynamic Effects of Ribavirin in Patients with Operable Tonsil Squamous Cell Carcinoma
[Protocol 10-218] |
Fury, Matthew |
|
A Phase I Study of Induction Chemotherapy with Afatinib, Ribavirin, and Carboplatin/Paclitaxel in Patients with Stage IV HPV-Associated Oropharynx Cancer
[Protocol 12-150] |
Fury, Matthew |
|
A Phase I Study of BKM120 with Carboplatin and Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 10-192] |
Fury, Matthew |
|
